Ulrich Laufs is an expert in Cardiology at University Hospital Leipzig (Germany). As of October 2026, ScienceLeadR ranks Ulrich Laufs in the top 1% of experts worldwide for Hypercholesterolemia, Dyslipidemias and Hyperlipidemias. Ulrich Laufs has authored 885 publications, the most recent in 2026, and is an investigator in 37 clinical trials, 4 of them ongoing. SLR score: 3,537 (community average: 125). How the SLR is computed.

LeadR Profile

Ulrich Laufs University Hospital Leipzig Germany
3 537 ScienceLeadR Reputation 3537
Network Map

Cardiology

Subspecialties: Biochemistry - Pharmacy - Public Health

Full career – Last 3 years

Main Topics

Publications and Clinical Studies

Publications – Clinical Studies

Profile data updated on

Organizations

Career arc: 1997 - 2026

Source: PubMed

University Hospital Leipzig

Publications Synthesis

Sources: PubMed, OpenAlex

Number : 885

Citations

Citations: 69 045 1st author: 81 Last author: 275 Unique author: 18


Breakdown by type

Click a legend label to hide or show it in the chart.

Latest Publications

5 most recent indexed articles

Source: Pubmed

Title Journal Year Citations
The effect of different exercise modalities on the maximal left ventricular outflow tract gradient in patients with obstructive hypertrophic cardiomyopathy.
PMID 42860537 — exercise, cardiomyopathy, hypertrophic, echocardiography, cardiomyopathies
Echo Res Pract20260
Long-term LDL-C lowering and treatment persistence with inclisiran: 3-year follow-up from the German Inclisiran Network.
PMID 42803952 — heart diseases, therapeutics, hydroxymethylglutaryl-coa reductase inhibitors
Clin Res Cardiol20260
Using a Stifneck Select CollarTM for hands-free semiautomatic blood flow measurements: A user study.
PMID 42777074 — skin, research design, blood, pain, cardiopulmonary resuscitation, solutions, blood circulation
PLoS One20260
Catheter ablation for symptomatic atrial fibrillation (PVI-SHAM-AF): a randomised, double-blind, sham-controlled, multicentre trial.
PMID 42669307 — quality of life, atrial fibrillation, catheter ablation, catheters
Lancet Top journal20264
The Current State of Care Delivery in Cardiac Rhythm Monitoring After Ischemic Stroke.
PMID 42687571 — ischemic stroke, stroke
Dtsch Arztebl Int20260

Clinical Studies 37

Sources: ClinicalTrials, EU CTIS

Synthesis

Principal Investigator: 3 Study Chair: 2 Study Director: 1

By phase:

N/A 18
Phase 3 14
Phase 4 5

By status:

Completed 27
Active not recruiting 3
Recruiting 3
Unknown 3
Not yet recruiting 1

By type:

Interventional 27
Observational 10

By Monocentric/Multicentric:

monocentric 11
multicentric2to4 4
multicentric5to9 3
multicentricup10 19

Main Topics

Cohort/Consortium Investigators 3

Ongoing Clinical Trials

4 ongoing trials started since 2021, where this expert is an investigator

Source: ClinicalTrials

Study Phase Status Start
Cholesterol Self testing in Patients Post Acute Coronary Syndrome
NCT06526013 — research design, achievement, hyperlipidemias, self-testing, cardiovascular diseases, dyslipidemias, acute coronary syndrome, cholesterol, therapeutics, hydroxymethylglutaryl-coa reductase inhibitors, hyperlipoproteinemias, lipids
N/ARecruiting2024
Intensive Lipid lowering in Patients With STEMI and NSTEMI (Germany on Target)
NCT05587621 — ezetimibe, cholesterol, ldl, myocardial infarction, food, st elevation myocardial infarction, cholesterol, therapeutics, software, hydroxymethylglutaryl-coa reductase inhibitors, non-st elevated myocardial infarction, lipids
N/ANot yet recruiting2024
Pulmonary Vein Isolation vs SHAM pulmonary Vein Isolation for Symptomatic Relief in Patients With AF
NCT05119231 — femoral vein, pulmonary veins, heart diseases, heart, arrhythmias, cardiac, deep sedation, electric countershock, arteries, atrial fibrillation, cryosurgery, radiofrequency ablation, therapeutics, catheter ablation, punctures, veins, catheters
N/AActive not recruiting2021
Statin Intolerance Registry
NCT04975594 — registries, muscles, dyslipidemias, lipid metabolism disorders, signs and symptoms, hydroxymethylglutaryl-coa reductase inhibitors, lipids
N/AActive not recruiting2021

LeadR Networks

Main global connection map